Truusome AI was founded on the belief that advanced technology should make better choices simpler, scalable, and sustainable. By transforming complex data into actionable intelligence, our platforms empower enterprises and governments to make decisions that drive long-term outcomes whether in health, operations, or resource management.
Liters - Water Saved
Kilograms - Co2 Emissions Saved
Acre - Land Footprint Saved
As of August 19, 2023, Truusome AI’s proprietary algorithms and platform technology were acquired by Orion Pharmaceuticals & Nutraceuticals (India). Under the terms of the agreement, Orion retains exclusive commercial rights for a period of five years, after which the intellectual property will transition to an open-source framework (subject to mutual agreement). This site provides a static archive of our earlier work, with certain details withheld due to confidentiality obligations under the acquisition terms. For updates regarding the future open-source release, or to explore potential collaborations, please contact us directly.
Hello! This is no longer an interactive chatbot. Use the button below to contact us on WhatsApp if you're interested in accessing our open-source algorithm for drug development after the exclusivity period.